Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus fentanyl as vaginal bupivacaine adjuvants for postoperative pain after pelvic floor surgery
IRCT20141209020258N193Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine + dexmedetomidine with Bupivacaine + fentanyl (2 arms). Primary endpoints: Pain, Nausea and vomiting and 1 more. Started Oct 2024; status: completed.
02
Drugs
dexmedetomidinefentanylbupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20141209020258N193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N193.